ORIC Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Wednesday, January 2, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

SOUTH SAN FRANCISCO, Calif., Jan. 2, 2019 /PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology

company focused on discovery and development of novel therapies against treatment-resistant cancers, announced that Jacob Chacko, MD, Chief Executive Officer, will be presenting at the 37th Annual J.P. Morgan
Healthcare Conference on Tuesday, Jan. 8, 2019, at 7:30 a.m. PST. The conference will be held at the Westin St. Francis in San Francisco. 

About ORIC Pharmaceuticals

ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline also includes an orally-available small molecule inhibitor of CD73, as well as other undisclosed programs targeting mechanisms of oncology therapy resistance. ORIC's scientific founders are Charles Sawyers, MD, and Scott Lowe, PhD, who have strong records of discovering novel targets in cancer that have led to innovative treatments.  The company has assembled strong leadership and scientific teams and a board with extensive experience in drug development and financing.  ORIC is funded by leading biotechnology investors, including The Column Group, Topspin Partners, OrbiMed, EcoR1, Fidelity, Foresite and others.  ORIC is headquartered in South San Francisco, California.

For more information, please contact:

Krys Corbett

650-388-5622

207014@email4pr.com

http://oricpharma.com/

Cision View original content:http://www.prnewswire.com/news-releases/oric-pharmaceuticals-to-present-at-jp-morgan-healthcare-conference-300771762.html

SOURCE ORIC Pharmaceuticals



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store